5 Biotech Stocks to Buy as New Drug Approvals Drive Industry ProspectsZacks Investment Research • 09/01/23
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%GlobeNewsWire • 08/28/23
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 08/24/23
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of DirectorsGlobeNewsWire • 08/23/23
ANI Pharmaceuticals (ANIP) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/09/23
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 GuidanceGlobeNewsWire • 08/09/23
ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ETGlobeNewsWire • 07/31/23
ANI Pharmaceuticals Is Undervalued When Considering Their Unadvertised PipelineSeeking Alpha • 07/05/23
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 05/16/23
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT ExclusivityBusiness Wire • 05/15/23
ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common StockBusiness Wire • 05/12/23
ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/08/23
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 GuidanceBusiness Wire • 05/08/23
ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ETBusiness Wire • 04/27/23
ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQBusiness Wire • 04/26/23